1.44
bioAffinity Technologies, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
12.0
FY23:
3.97
FY24:
2.70
FY25:
7.57
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.02
FY22:
0.22
FY23:
4.25
FY24:
3.82
FY25:
3.40
Total assets
Change from FY21 to FY25
millions USD
FY21:
1.45
FY22:
12.2
FY23:
8.22
FY24:
6.51
FY25:
11.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
13.0
FY22:
1.14
FY23:
2.25
FY24:
3.10
FY25:
2.91
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.16
FY22:
0
FY23:
1.12
FY24:
0.81
FY25:
0.78
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.8
FY22:
11.0
FY23:
4.86
FY24:
2.60
FY25:
7.28
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
12.2
FY23:
8.22
FY24:
6.51
FY25:
11.0
All amounts in millions USD